Home › Medical
ASCCP Management Guidelines
Information
Preview 2 platforms
iPhone 4 images
iPad 4 images
What’s New Version 2.4.2
- Updated screening section
Description
The ASCCP Risk-Based Management Consensus Guidelines provide evidence-based recommendations for managing abnormal cervical cancer screening results and cancer precursors, including post-colposcopy and post-treatment scenarios.
ASCCP is pleased to offer this app to streamline navigation of the ASCCP Risk-Based Management Consensus Guidelines for abnormal cervical cancer screening tests and cancer precursors. The guidelines articles, as published in the Journal of Lower Genital Tract Disease, as well as the comprehensive risk estimates, can be accessed through https://www.asccp.org/guidelines.
These evidence-based management guidelines, initially developed in 2019, came together through a consensus process of 19 organizations. The updated management guidelines aim to:
• Allow for a more complete and precise estimation of risk
• Provide more appropriate intervention for high-risk individuals (detect and treat more precancer)
• Recommend less intervention for low-risk individuals (decrease testing and treatment that won’t prevent cancer and may cause reproductive harm)
• Allow for the future addition of new risk modifiers and screening and management technologies
See https://www.asccp.org/UserGuide for tips on using the app.
Accessibility
ipadiphonemacrealityDevicetvoswatch
Version history 16 versions
Build 887457668v2.4.22026-06-25 22:49:54
- Updated screening section
Build 880665535v2.4.12026-03-04 19:44:09
Incorporates HPV Self-Collection Recommendations
Build 878900857v2.42025-10-30 16:40:11
Incorporates HPV Self-Collection Recommendations
Build 876003515v2.32025-07-31 00:47:35
Extended HPV Genotyping Support.
Build 875949478v2.22025-06-28 09:01:18
Expanded post-colposcopy guidance and updated ASC-US cotest recommendations.
Build 872364319v2.1.12025-03-17 05:26:38
Dual Stain Management:
We’ve introduced enhanced support for managing Dual Stain results, providing a streamlined approach for more accurate analysis and decision-making.
SmartUI Enhancement:
Our updated SmartUI now intelligently guides you through patient history, enabling faster, more efficient recommendations based on key data points.
Build 869880440v2.12025-02-01 20:35:26
Dual Stain Management:
We’ve introduced enhanced support for managing Dual Stain results, providing a streamlined approach for more accurate analysis and decision-making.
SmartUI Enhancement:
Our updated SmartUI now intelligently guides you through patient history, enabling faster, more efficient recommendations based on key data points.
Build 869657666v2.0.12024-10-11 17:04:08
Dual Stain Management:
We’ve introduced enhanced support for managing Dual Stain results, providing a streamlined approach for more accurate analysis and decision-making.
SmartUI Enhancement:
Our updated SmartUI now intelligently guides you through patient history, enabling faster, more efficient recommendations based on key data points.
Build 849205746v2.02024-10-10 16:42:54
Dual Stain Management:
We’ve introduced enhanced support for managing Dual Stain results, providing a streamlined approach for more accurate analysis and decision-making.
SmartUI Enhancement:
Our updated SmartUI now intelligently guides you through patient history, enabling faster, more efficient recommendations based on key data points.
Build 846582234v1.72022-02-24 23:02:16
Recommendation updates based on new erratum publication.
Build 844871941v1.62021-11-25 01:09:35
Minor improvements to management recommendations and typographical errors
Build 842101827v1.52021-09-24 18:00:53
New Clinical Situations tree to aide in navigation.
Expanded app to include Screening Guidelines.
Build 840768227v1.32021-04-09 19:49:30
New 2019 ASCCP Risk-Based Management Consensus Guidelines for abnormal cervical cancer screening tests and cancer precursors provide new recommendations.
Build 837998175v1.22020-10-01 21:58:09
New 2019 ASCCP Risk-Based Management Consensus Guidelines for abnormal cervical cancer screening tests and cancer precursors provide new recommendations.
Build 836379089v1.12020-08-19 18:47:21
New 2019 ASCCP Risk-Based Management Consensus Guidelines for abnormal cervical cancer screening tests and cancer precursors provide new recommendations.
Build 834666443v1.02020-06-05 19:21:54
Price history by region
Currency
Show
Columns
Search
App performance US
Availability 1 of 1 storefronts
| Region | Language | Price | Ratings | Avg | Version |
|---|---|---|---|---|---|
US | en-US | USD 14.99 | 8.5k | 4.8 | 2.4.2 |
Change log 19 changes · US
✎
releaseNotes updated
- Updated screening section
✎
description updated
The ASCCP Risk-Based Management Consensus Guidelines provide evidence-based recommendations for managing abnormal cervical cancer screening results and cancer p
✎
name updated
ASCCP Management Guidelines
◆
Version 2.4.2 released
- Updated screening section
◆
Version 2.4.1 released
Incorporates HPV Self-Collection Recommendations
◆
Version 2.4 released
Incorporates HPV Self-Collection Recommendations
◆
Version 2.3 released
Extended HPV Genotyping Support.
◆
Version 2.2 released
Expanded post-colposcopy guidance and updated ASC-US cotest recommendations.
◆
Version 2.1.1 released
Dual Stain Management:
We’ve introduced enhanced support for managing Dual Stain results, providing a streamlined approach for more accurate analysis and decision-making.
SmartUI Enhancement:
Our updated SmartUI now intelligently guides yo
◆
Version 2.1 released
Dual Stain Management:
We’ve introduced enhanced support for managing Dual Stain results, providing a streamlined approach for more accurate analysis and decision-making.
SmartUI Enhancement:
Our updated SmartUI now intelligently guides yo
◆
Version 2.0.1 released
Dual Stain Management:
We’ve introduced enhanced support for managing Dual Stain results, providing a streamlined approach for more accurate analysis and decision-making.
SmartUI Enhancement:
Our updated SmartUI now intelligently guides yo
◆
Version 2.0 released
Dual Stain Management:
We’ve introduced enhanced support for managing Dual Stain results, providing a streamlined approach for more accurate analysis and decision-making.
SmartUI Enhancement:
Our updated SmartUI now intelligently guides yo
◆
Version 1.7 released
Recommendation updates based on new erratum publication.
◆
Version 1.6 released
Minor improvements to management recommendations and typographical errors
◆
Version 1.5 released
New Clinical Situations tree to aide in navigation.
Expanded app to include Screening Guidelines.
◆
Version 1.3 released
New 2019 ASCCP Risk-Based Management Consensus Guidelines for abnormal cervical cancer screening tests and cancer precursors provide new recommendations.
◆
Version 1.2 released
New 2019 ASCCP Risk-Based Management Consensus Guidelines for abnormal cervical cancer screening tests and cancer precursors provide new recommendations.
◆
Version 1.1 released
New 2019 ASCCP Risk-Based Management Consensus Guidelines for abnormal cervical cancer screening tests and cancer precursors provide new recommendations.
◆
Version 1.0 released